Looking ahead, Piller remains cautiously optimistic. Despite the setbacks and missteps, he sees a field ready for change, driven by scientists determined to explore new avenues. Whether it’s research into infections, tau proteins, or GLP-1 inhibitors, fresh perspectives offer renewed hope.
